SciLocyte

SciLocyte Overdosage

filgrastim

Manufacturer:

SciGen

Distributor:

Metro Drug
Full Prescribing Info
Overdosage
In cancer patients receiving Recombinant G-CSF as an adjunct to myelosuppressive chemotherapy, it is recommended, to avoid the potential risks of excessive leukocytosis that Recombinant G-CSF therapy be discontinued if the ANC surpasses 10,000/mm3 after the chemotherapy-induced ANC nadir has occurred.
Patients in the BMT studies received up to 138 mcg/kg/day without toxic effects, although there was a flattening of the dose response curve above daily doses of greater than 10 mcg/kg/day.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in